{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:20:55Z","timestamp":1784805655481,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalimaging.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Imaging"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.clinimag.2022.09.009","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T02:19:26Z","timestamp":1664504366000},"page":"57-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Brain MRI and clinical exam findings in women with multiple gadolinium-based contrast agent (GBCA) exposures due to screening breast MRIs"],"prefix":"10.1016","volume":"92","author":[{"given":"Kelly S.","family":"Myers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Yousem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Gad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaz Ghaderi","family":"Niri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Bienko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Munro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinimag.2022.09.009_bb0005","series-title":"FDA Drug Safety Communication: FDA WarnsThat Gadolinium-based Contrast Agents (GBCAs) are Retained in the Body; RequiresNew Class Warnings","year":"2017"},{"issue":"2","key":"10.1016\/j.clinimag.2022.09.009_bb0010","first-page":"75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography","volume":"52","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin."},{"key":"10.1016\/j.clinimag.2022.09.009_bb0015","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/0306-4522(82)90019-7","article-title":"The gadolinium ion: a potent blocker of calcium channels and catecholamine release from cultured chromaffin cells","volume":"7","author":"Bourne","year":"1982","journal-title":"Neuroscience"},{"key":"10.1016\/j.clinimag.2022.09.009_bb0020","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1126\/science.2466333","article-title":"Block of stretch-activated ion channels in xenopus oocytes by gadolinium and calcium ions","volume":"243","author":"Yang","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.clinimag.2022.09.009_bb0025","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00234-020-02434-8","article-title":"Exposure to gadolinium and neurotoxicity: current status of preclinical and clinical studies","volume":"62","author":"Mallio","year":"2020","journal-title":"Neuroradiology"},{"key":"10.1016\/j.clinimag.2022.09.009_bb0030","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1148\/radiol.13131669","article-title":"High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MRI images: relationship with increasing cumulative dose of a gadolinium-based contrast material","volume":"270","author":"Kanda","year":"2014","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.clinimag.2022.09.009_bb0035","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1148\/radiol.15150025","article-title":"Intracranial gadolinium deposition after contrast-enhanced MR imaging","volume":"275","author":"McDonald","year":"2015","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.clinimag.2022.09.009_bb0040","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1148\/radiol.2017161595","article-title":"Gadolinium deposition in human brain tissues after contrast-enhanced MR imaging in adult patients without intracranial abnormalities","volume":"285","author":"McDonald","year":"2017","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.clinimag.2022.09.009_bb0045","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s00247-019-04535-w","article-title":"Brain tissue gadolinium retention in pediatric patients after contrast-enhanced magnetic resonance exams: pathological confirmation","volume":"50","author":"Stanescu","year":"2020","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.clinimag.2022.09.009_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11604-015-0503-5","article-title":"Brain gadolinium deposition after administration of gadolinium-based contrast agents","volume":"34","author":"Kanda","year":"2016","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.clinimag.2022.09.009_bb0055","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/RLI.0000000000000252","article-title":"Macrocyclic and other non-group 1 gadolinium contrast agents deposit low levels of gadolinium in brain and bone tissue: preliminary results from 9 patients with normal renal function","volume":"51","author":"Murata","year":"2016","journal-title":"Invest Radiol"},{"key":"10.1016\/j.clinimag.2022.09.009_bb0060","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1148\/radiol.14140364","article-title":"High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: association with linear versus macrocyclic gadolinium chelate administration","volume":"275","author":"Kanda","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.clinimag.2022.09.009_bb0065","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2214\/AJR.15.15327","article-title":"Signal change in the dentate nucleus on T1-weighted MR images after multiple administrations of gadopentetate dimeglumine versus gadobutrol","volume":"206","author":"Cao","year":"2016","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.clinimag.2022.09.009_bb0070","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/RLI.0000000000000206","article-title":"Increased signal intensity in the dentate nucleus on unenhanced T1-weighted images after gadobenate dimeglumine administration","volume":"50","author":"Weberling","year":"2015","journal-title":"Invest Radiol"},{"key":"10.1016\/j.clinimag.2022.09.009_bb0075","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/RLI.0000000000000227","article-title":"High-signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evaluation of the macrocyclic gadolinium-based contrast agent gadobutrol","volume":"50","author":"Radbruch","year":"2015","journal-title":"Invest Radiol"},{"key":"10.1016\/j.clinimag.2022.09.009_bb0080","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1148\/radiol.2015150337","article-title":"Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent","volume":"275","author":"Radbruch","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.clinimag.2022.09.009_bb0085","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/RLI.0000000000000154","article-title":"Gadodiamide and dentate nucleus T1 hyperintensity in patients with meningioma evaluated by multiple follow-up contrast-enhanced magnetic resonance examinations with no systemic interval therapy","volume":"50","author":"Quattrocchi","year":"2015","journal-title":"Invest Radiol"},{"issue":"12","key":"10.1016\/j.clinimag.2022.09.009_bb0090","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1007\/s00330-016-4245-2","article-title":"In vivo dentate nucleus MRI relaxometry correlates with previous administration of gadolinium-based contrast agents","volume":"26","author":"Tedeschi","year":"2016","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.clinimag.2022.09.009_bb0095","article-title":"The presence of the","volume":"12","author":"Olchowy","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.clinimag.2022.09.009_bb0100","article-title":"MRI and quantitative magnetic susceptibility maps of the brain after serial administration of gadobutrol: a longitudinal follow-up study","volume":"21","author":"Choi","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.clinimag.2022.09.009_bb0105","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/RLI.0000000000000072","article-title":"Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation","volume":"49","author":"Errante","year":"2014","journal-title":"Invest Radiol"},{"key":"10.1016\/j.clinimag.2022.09.009_bb0110","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1148\/radiol.2015150872","article-title":"High signal intensity in globus pallidus and dentate nucleus on unenhanced T1-weighted MR images: evaluation of two linear gadolinium-based contrast agents","volume":"276","author":"Ramalho","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.clinimag.2022.09.009_bb0115","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00330-015-3879-9","volume":"26","author":"Stojanov","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.clinimag.2022.09.009_bb0120","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/jon.12448","article-title":"Sodium MRI of T1 high signal intensity in the dentate nucleus due to gadolinium deposition in multiple sclerosis","volume":"27","author":"Eisele","year":"2017","journal-title":"J Neuroimaging"},{"issue":"3","key":"10.1016\/j.clinimag.2022.09.009_bb0125","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00062-021-00995-6","article-title":"Signal intensity evaluation in the dentate nucleus and subcortical gray matter: Effect of Several Administrations of Gadoterate Meglumine in Multiple Sclerosis","volume":"32","author":"Hannoun","year":"2022","journal-title":"Clin Neuroradiol"},{"issue":"1","key":"10.1016\/j.clinimag.2022.09.009_bb0130","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12968-020-00676-2","article-title":"Assessment of gadolinium deposition in the brain tissue of pediatric and adult congenital heart disease patients after contrast enhanced cardiovascular magnetic resonance","volume":"22","author":"Zaki","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.clinimag.2022.09.009_bb0135","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1007\/s00415-017-8631-8","article-title":"Absence of clinical cerebellar syndrome after serial injections of more than 20 doses of gadoterate, a macrocyclic GBCA: a monocenter retrospective study","volume":"264","author":"Perrotta","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.clinimag.2022.09.009_bb0140","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00234-018-02150-4","article-title":"MRI features suggestive of gadolinium retention do not correlate with expanded disability status scale worsening in multiple sclerosis","volume":"61","author":"Cocozza","year":"2019","journal-title":"Neuroradiology"},{"key":"10.1016\/j.clinimag.2022.09.009_bb0145","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/jmri.26669","article-title":"Absence of dentate nucleus resting-state functional connectivity changes in nonneurological patients with gadolinium-related hyperintensity on T1-weighted images","volume":"50","author":"Mallio","year":"2019","journal-title":"J Magn Reson Imaging"},{"issue":"93","key":"10.1016\/j.clinimag.2022.09.009_bb0150","first-page":"e611","article-title":"Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS","volume":"6","author":"Zivadinov","year":"2019","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.clinimag.2022.09.009_bb0155","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2214\/ajr.172.4.10587157","article-title":"Hyperintense basal ganglia on T1-weighted MR imaging","volume":"172","author":"Lai","year":"1999","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clinimag.2022.09.009_bb0160","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually","volume":"81","author":"Gail","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clinimag.2022.09.009_bb0165","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A breast cancer prediction model incorporating familial and personal risk factors","volume":"23","author":"Tyrer","year":"2004","journal-title":"Stat Med"},{"issue":"6","key":"10.1016\/j.clinimag.2022.09.009_bb0170","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1080\/13854040802603684","article-title":"Development, psychometric properties, and validity of the Hopkins adult Reading test (HART)","volume":"23","author":"Schretlen","year":"2009","journal-title":"Clin Neuropsychol"},{"key":"10.1016\/j.clinimag.2022.09.009_bb0175","series-title":"Wechsler Adult Intelligence Scale","article-title":"Third Edition administration and scoring manual","author":"Wechsler","year":"1997"},{"key":"10.1016\/j.clinimag.2022.09.009_bb0180","series-title":"Brain and intelligence","author":"Halstead","year":"1947"},{"key":"10.1016\/j.clinimag.2022.09.009_bb0185","series-title":"The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation","author":"Reitan","year":"1993"},{"issue":"2","key":"10.1016\/j.clinimag.2022.09.009_bb0190","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0028-3932(67)90015-2","article-title":"Word fluency and brain damage","volume":"5","author":"Borkowski","year":"1967","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.clinimag.2022.09.009_bb0195","series-title":"Hopkins Verbal Learning Test\u2013Revised Professional Manual","author":"Brandt","year":"2001"},{"key":"10.1016\/j.clinimag.2022.09.009_bb0200","series-title":"Rey Complex Figure Test and Recognition Trial Professional Manual","author":"Meyers","year":"1995"},{"issue":"5","key":"10.1016\/j.clinimag.2022.09.009_bb0205","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1037\/0012-1649.27.5.763","article-title":"Decomposing adult age differences in working memory","volume":"27","author":"Salthouse","year":"1991","journal-title":"Dev Psychol"},{"key":"10.1016\/j.clinimag.2022.09.009_bb0210","series-title":"The Medical Clinics of North America","article-title":"Clinical neuropsychology","author":"Klove","year":"1963"},{"issue":"1","key":"10.1016\/j.clinimag.2022.09.009_bb0215","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","article-title":"Development and validation of a geriatric depression screening scale: a preliminary report","volume":"17","author":"Yesavage","year":"1982","journal-title":"J Psychiatr Res"},{"issue":"1","key":"10.1016\/j.clinimag.2022.09.009_bb0220","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-93147-2","article-title":"Repeat and single dose administration of gadodiamide to rats to investigate concentration and location of gadolinium and the cell ultrastructure","volume":"11","author":"Davies","year":"2021","journal-title":"Sci Rep."}],"container-title":["Clinical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707122002418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707122002418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:49:46Z","timestamp":1760269786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899707122002418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":44,"alternative-id":["S0899707122002418"],"URL":"https:\/\/doi.org\/10.1016\/j.clinimag.2022.09.009","relation":{},"ISSN":["0899-7071"],"issn-type":[{"value":"0899-7071","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain MRI and clinical exam findings in women with multiple gadolinium-based contrast agent (GBCA) exposures due to screening breast MRIs","name":"articletitle","label":"Article Title"},{"value":"Clinical Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinimag.2022.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}